Fig. 2From: Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitusCT images of pancreas obtained before and after ICI-DM in patient 1, a patient in their 70s with lung adenocarcinoma who received anti-PD-1 therapy. (A) Pre-treatment CT scan without evidence of pancreatic atrophy. (B) Post-treatment CT scan performed 2 months after ICI-DM demonstrating a significant decrease in pancreatic sizeBack to article page